Physician profile
Vivek Rajagopal
NPI 1598988149
$7,642.44
in general payments reported to CMS, 2019-2025
14 companies · $647 in 2025
The $647 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,252 · 2020: $386 · 2021: $537 · 2022: $763 · 2023: $699 · 2024: $360 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,235.10 | 2019-2025 | Mitraclip, Amplatzer Talisman, Navitor |
| Boston Scientific Corporation | $1,714.05 | 2019 | |
| Edwards Lifesciences Corporation | $1,398.06 | 2019-2025 | Sapien 3 Ultra Resilia |
| Ancora Heart, INC. | $771.60 | 2019-2020 | |
| Saranas, INC. | $149.33 | 2022 | |
| Medtronic Vascular, INC. | $109.44 | 2019 | |
| Angiodynamics, INC. | $98.63 | 2025 | Angiovac |
| Medtronic, INC. | $59.44 | 2025 | Penditure, Symplicity G3 |
| Cardiva Medical, INC. | $21.80 | 2024 | Ensoetm |
| Abiomed | $20.93 | 2025 | |
| Teleflex LLC | $19.19 | 2025 | Guideliner |
| Pfizer INC. | $19.09 | 2025 | |
| Resmed Corp | $13.31 | 2022 | |
| Baxter Healthcare | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Rajagopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.